Revalidação do painel sorológico empregado na avaliação dos kits de diagnóstico da doença de Chagas

Introduction: Acute phase of Chagas disease is characterised by the presence of blood parasites while in the chronic phase, parasite titres decrease and antibodies increase.  According to RDC nº 36, of August 26, 2015, diagnostic tests for the disease belong to risk class IV, with mandatory registration with the National Health Surveillance Agency. The performance of these products is assessed in the laboratory analysis prior to registration, against serological panels composed of true positive and negative samples. Objective:  Revalidate the serological panel composed of true positive samples for Chagas disease  used in the analysis of in vitro diagnostic kits for the detection of specific antibodies against Trypanosoma cruzi. Method: Revalidation of the Chagas serological panel by retrospective analysis of results obtained in the methodologies: ELISA, Rapid Test, Immunofluorescence, Agglutination, Hemagglutination and Chemiluminescence, meeting the criteria of: positivity in 02 Rapid Tests; 03 Immunofluorescences; 01 Agglutination Test; 05 ELISAS, 02 Hemagglutination Tests, 03 Chemiluminescences and volume ≥ 10 mL. Results: 45 kits with a satisfactory report were selected, being 60.0% ELISA, 16.0% immunofluorescence, 11.0%  chemiluminescence, 7.0%  hemagglutination, 4.0% immunochromatographic test and 2.0% agglutination. 160 records were evaluated, 56.2% of which were destined for ELISA, 14.4% of chemiluminescence, 13.1% of immunoflurescence, 8.1% of hemagglutination, 5.6% of rapid tests and 2.5% of agglutination. A standardized spreadsheet was prepared to insert the data in Excel® and evaluate the samples against the methodologies. A total of 64 samples were revalidated. Conclusions: The revalidated Panel, composed of 64 samples, was characterized and its use guarantees reliable results, expanding the analytical capacity of the Laboratory of Blood and Blood Products in the quality control of diagnostic kits.Introdução: A doença de Chagas apresenta infecção aguda com alta parasitemia e crônica com queda da parasitemia e aumento de anticorpos. Segundo a RDC nº 36, de 26 de agosto de 2015, os testes de diagnóstico da doença pertencem à classe de risco IV, com obrigatoriedade de registro junto a Agência Nacional de Vigilância Sanitária. O desempenho desses produtos é avaliado na análise laboratorial prévia ao registro, frente a painéis sorológicos compostos por amostras verdadeiro-positivas e negativas. Objetivo: Revalidar o painel sorológico composto de amostras verdadeiro-positivas para doença de Chagas utilizado na análise de kits de diagnóstico in vitro destinados à detecção de anticorpos específicos contra Trypanosoma cruzi. Método: Revalidação do painel sorológico de Chagas por análise retrospectiva de resultados obtidos nas metodologias: ELISA, teste imunocromatográfico, imunofluorescência, aglutinação, hemaglutinação e quimioluminescência, atendendo aos critérios de: positividade em dois testes rápidos; três imunofluorescências; um teste de aglutinação; cinco ELISA, dois testes de hemaglutinação; três de quimioluminescências e  volume ≥ 10 mL. Resultados: Foram selecionados 45 kits com laudo satisfatório, sendo 60,0% ELISA, 16,0%  imunofluorescência, 11,0% quimioluminescência, 7,0% hemaglutinação,  4,0% teste imunocromatográfico e 2,0% aglutinação. Foram avaliados 160 registros nos quais, 56,2% destinados a ELISA, 14,4% de quimioluminescência, 13,1% de imunoflurescência,  8,1% de hemaglutinação, 5,6% de testes rápidos e 2,5% de aglutinação. Foi elaborada uma planilha padronizada para inserção dos dados em Excel® e avaliação das amostras frente às metodologias. Um total de 64 amostras foi revalidado. Conclusões: O painel revalidado, composto por 64 amostras, foi caracterizado e seu uso garante resultados confiáveis, ampliando a capacidade analítica do Laboratório de Sangue e Hemoderivados no controle de qualidade de kits para diagnóstico

Revalidação do painel sorológico destinado a avaliação de kits para o diagnóstico sorológico do HIV

Introduction: Kits used in the diagnosis of the human immunodefciency virus (HIV) must meet the requirements of RDC No. 36, of August 26, 2015 for registration with the National Health Surveillance Agency and Law No. 6.360, of September 23 1976 for commercialization in the country. One of the registration steps corresponds to the previous laboratory analysis of the products with the highest risk class (class IV), carried out by the Laboratory of Blood and Blood Products (LSH). In the analysis of the products, serological panels consisting of true positive samples are used as the main tool in the  sensitivity assessment. Objective: To revalidate a true HIV positive serological panel for the evaluation of in vitro HIV diagnostic kits. Method: A  retrospective evaluation and selection of the panel results was performed against the kits that obtained satisfactory results and were received for prior analysis from January 2010 to December 2011. The reactivity of the panel samples in three immunoenzymatic assays (ELISA), in three  chemiluminescence assays (CLIA), in three immunochromatographic assays (rapid tests) and in three western blots was used as revalidation criterion; and reactivity in an enzyme-linked fluorescent enzyme assay (ELFA), in addition to a volume equal to or greater than 1 mL. Results: During the period, 73 kits for in vitro diagnosis of HIV  infection were received for analysis at the LSH, 47 (64.4%) of which were satisfactory, distributed as follows: 43.0% (20/47) ELISA, 34.0% (16/47) immunochromatographic assays, 13.0% (06/47) western blot, 2.0% (01/47) ELFA, 8.0% (04/47) chemiluminescence assays. After the evaluation, 77.0% (34/44) of the units were revalidated, and 23.0% (10/44) were excluded from the panel, as they did not meet the established criteria. Conclusions: The revalidated panel currently consists of 34 units of true positive samples, with consistent results, thus increasing the reliability and safety of the analyses carried out and of the tests marketed in the  country.Introdução:Os kits empregados no diagnóstico do vírus da imunodefciência humana (HIV) devem  cumprir requisitos da RDC n° 36, de 26 de agosto de 2015, para registro junto à Agência Nacional de Vigilância Sanitária e da Lei n° 6.360, de 23 de setembro de 1976, para comercialização no país. Uma das etapas do registro é a análise prévia laboratorial dos produtos de maior classe de risco (classe IV), realizada pelo Laboratório de Sangue e  Hemoderivados (LSH). Na análise dos produtos são utilizados painéis sorológicos constituídos de  amostras verdadeiro positivas como principal ferramenta na avaliação de sensibilidade. Objetivo: Revalidar painel sorológico verdadeiro positivo para HIV, destinado à avaliação de kits de diagnóstico in vitro do HIV. Método: Foram realizadas a avaliação retrospectiva e a seleção dos resultados do painel frente aos kits recebidos para análise prévia de janeiro de 2010 a dezembro de 2011 que obtiveram resultado satisfatório. Foi utilizado como critério de revalidação a reatividade das amostras do painel em três ensaios imunoenzimáticos (ELISA), em três  ensaios de quimiluminescência (CLIA), em três ensaios imunocromatográfcos (testes rápidos) e em três western blot; e reatividade em um ensaio enzimático fluorescente ligado à enzima (ELFA), além do volume igual ou superior a 1 mL. Resultados: No período foram recebidos para análise no LSH 73 kits para diagnóstico in vitro da infecção pelo HIV, sendo 47 (64,4%) satisfatórios, assim distribuídos: 43,0% (20/47) ELISA, 34,0% (16/47) ensaios imunocromatográfcos, 13,0% (06/47) western blot, 2,0% (01/47) ELFA e 8,0% (04/47) ensaios de quimiluminescência. Após a avaliação, 77,0% (34/44) das unidades foram revalidadas, sendo excluídas do painel 23,0% (10/44), pois não alcançaram os critérios estabelecidos. Conclusões: O painel revalidado atualmente é composto por 34 unidades de amostras verdadeiro positivas, com resultados consistentes, aumentando, assim, a confabilidade e a segurança das análises realizadas e dos testes comercializados no país

Monitoramento pós-mercado dos testes rápidos para COVID-19: enfrentamento da pandemia:

Introduction: In December 2019, the  first group of patients with symptoms of atypical pneumonia was discovered in Wuhan, China. On January 7, 2020, the etiologic agent was identified; it was a new betacoronavirus, genetically similar to SARS-CoV-1, consisting of a simple RNA strand, an enveloped virus of 50-200nm in diameter, which was called SARS-CoV-2. Soon after, the disease was named COVID-19. On January 30, WHO declared a Public Health Emergency of International Importance due to the spread of the coronavirus. Tests for serological detection of IgM and IgG antibodies are those that provide an estimate of the immune response to SARS-CoV-2, highlighting the Rapid Diagnostic Tests (RDT), simple and accessible with a result within 5-30 minutes, based on sensitization of antigens/antibodies conjugated to colloidal gold capturing specific proteins present in the infected serum, plasma or blood. Objective: This work aims to show the analysis carried out with RDT for COVID-19 diagnosis in compliance with the current legislation from 02.04 to 18.08.2020. Method: In March of 2020, 25 serum/plasma samples were donated, without any identification. These samples were the remaining samples of tests performed on individuals with a confirmed diagnosis of SARS-CoV-2 infection by the RT-PCR technique from health services (National Institute of Infectious Diseases Evandro Chagas – INI and State Institute of the Brain Paulo Niemeyer – IEC) located in the metropolitan region of the state of Rio de Janeiro. The samples obtained in order to become a serological panel were stored at -20ºC until the moment of use. Simultaneously, a panel of samples with confirmed reactivity for IgM and IgG antibodies from COVID-19 was being made, throughout the pandemic and the samples used were evaluated against three Rapid Tests, of different antigenic compositions or different brands; two ELISA tests for IgM and IgG; two chemiluminescence tests and when applicable, a molecular test. In order to assess the specificity of the products sent, surplus donation plasma samples were selected, known to be negative for HIV, HTLV, hepatitis b and c, chagas and syphilis, collected between 2013 and 2014, in the southern regions of the country, period in which SARS-CoV-2 was nonexistent in the world. In addition to True Positive (VP) and True Negative (VN) samples, interfering serum or plasma samples with reactivity for HIV, HCV, HTLV, HBsAg, chagas disease, syphilis and dengue were also included in the evaluation. Results:  Out of 178 TR lots, 74.1%, 132 lots were from China and 25.9%, 46 TR lots were from Brazil; Germany; South Korea; Canada; USA; Singapore; Ireland and Switzerland. The analytical result showed that 57.0%, 101 TR lots obtained a Satisfactory result and 43%, 77 lots had Unsatisfactory results, when compared to the Sensitivity and Specificity values declared by the manufacturer, in the Instructions for Use. Conclusions:The results obtained show the need for constant monitoring of TRs for COVID-19 with the primary purpose of guaranteeing the quality of products sold in the country, one of the National Health Surveillance System pillars of action.  Introdução: Em dezembro de 2019, foi descoberto na cidade de Wuhan, China, um primeiro grupo de pacientes com sintomas de uma pneumonia atípica. Em 7 de janeiro de 2020, o seu agente etiológico foi identificado: tratava-se de um novo betacoronavírus, geneticamente similar ao SARS-CoV-1, constituído defita simples de RNA, vírus envelopado de 50-200 nm de diâmetro designado como SARS-CoV-2, e a doença foi denominada COVID-19. Em 30 de janeiro, a Organização Mundial da Saúde declarou Emergência de Saúde Pública de Importância Internacional em razão da disseminação desse novo vírus. Os testes para detecção sorológica de anticorpos IgM e IgG fornecem uma estimativa da resposta imune ao SARS-CoV-2, com destaque para os Testes Rápidos (TR) que são simples e acessíveis fornecendo resultados em 5-30 min. Esses testes são sensibilizados com antígenos/anticorpos conjugados ao ouro coloidal, capturando proteínas específicas presentes no soro, plasma ou sangue de pacientes infectados. Objetivo: Demonstrar a análise efetuada nos TR para diagnóstico da COVID-19, em atendimento a legislação vigente, no período de 2 de abril a 18 de agosto de 2020. Método: Durante o mês de março de 2020, foram cedidas 25 amostras de soro/plasma, sem qualquer identificação, excedentes dos testes efetuados em indivíduos com diagnóstico confirmado de infecção pelo SARS-CoV-2 pela técnica de RT-PCR provenientes de serviços de saúde (InstitutoNacional de Infectologia Evandro Chagas – INI e Instituto Estadual do Cérebro Paulo Niemeyer – IEC) localizados na região metropolitana do estado do Rio de Janeiro. As amostras obtidas para a confecção de painel sorológico foram armazenadas a -20ºC até o momento do uso. Concomitantemente, um painel de amostras com reatividade confirmada para anticorpos IgM e IgG da COVID-19 foi sendo confeccionado ao longo da pandemia e as amostras utilizadas foram avaliadas frente a três TR, de diferentes composições antigênicas ou diferentes marcas; dois testes ELISA para IgM e IgG; dois testes de quimioluminescência e quando aplicável, um teste molecular. Para avaliação da especificidade dos produtos encaminhados, foram selecionadas amostras de plasma excedentes de doação, sabidamente negativas para HIV, HTLV, hepatite B e C, doença de chagas e sífilis coletadas nos anos de 2013 e 2014, na Região Sul do país, período no qual o SARS-CoV-2 era inexistente. Além de amostras Verdadeiro Positivas (VP) e Verdadeiro Negativas (VN), ainda foram incluídas na avaliação amostras de soro ou plasma interferentes com reatividade para HIV, HCV, HTLV, HBsAg, doença de chagas, sífilis e dengue. Resultados:  Dos 178 lotes de TR, 74,1% foram provenientes da China e 25,9%, do Brasil, da Alemanha, da Coreia do Sul, do Canadá, dos EUA, da Cingapura,da Irlanda e da Suíça. O resultado analítico demonstrou que 57,0% dos TR obtiveram resultados satisfatórios e 43,0%, resultados insatisfatórios, quando comparados aos valores de sensibilidade e especificidade declarados pelo fabricante na instrução de uso. Conclusões: Há necessidade de constante monitoramento dos TR para COVID-19, com finalidade precípua de garantir a qualidade dos produtos comercializados no país, um dos pilares das ações do Sistema Nacional de Vigilância Sanitária

Robust estimation of bacterial cell count from optical density

Optical density (OD) is widely used to estimate the density of cells in liquid culture, but cannot be compared between instruments without a standardized calibration protocol and is challenging to relate to actual cell count. We address this with an interlaboratory study comparing three simple, low-cost, and highly accessible OD calibration protocols across 244 laboratories, applied to eight strains of constitutive GFP-expressing E. coli. Based on our results, we recommend calibrating OD to estimated cell count using serial dilution of silica microspheres, which produces highly precise calibration (95.5% of residuals <1.2-fold), is easily assessed for quality control, also assesses instrument effective linear range, and can be combined with fluorescence calibration to obtain units of Molecules of Equivalent Fluorescein (MEFL) per cell, allowing direct comparison and data fusion with flow cytometry measurements: in our study, fluorescence per cell measurements showed only a 1.07-fold mean difference between plate reader and flow cytometry data

VIII Encuentro de Docentes e Investigadores en Historia del Diseño, la Arquitectura y la Ciudad

Acta de congresoLa conmemoración de los cien años de la Reforma Universitaria de 1918 se presentó como una ocasión propicia para debatir el rol de la historia, la teoría y la crítica en la formación y en la práctica profesional de diseñadores, arquitectos y urbanistas. En ese marco el VIII Encuentro de Docentes e Investigadores en Historia del Diseño, la Arquitectura y la Ciudad constituyó un espacio de intercambio y reflexión cuya realización ha sido posible gracias a la colaboración entre Facultades de Arquitectura, Urbanismo y Diseño de la Universidad Nacional y la Facultad de Arquitectura de la Universidad Católica de Córdoba, contando además con la activa participación de mayoría de las Facultades, Centros e Institutos de Historia de la Arquitectura del país y la región. Orientado en su convocatoria tanto a docentes como a estudiantes de Arquitectura y Diseño Industrial de todos los niveles de la FAUD-UNC promovió el debate de ideas a partir de experiencias concretas en instancias tales como mesas temáticas de carácter interdisciplinario, que adoptaron la modalidad de presentación de ponencias, entre otras actividades. En el ámbito de VIII Encuentro, desarrollado en la sede Ciudad Universitaria de Córdoba, se desplegaron numerosas posiciones sobre la enseñanza, la investigación y la formación en historia, teoría y crítica del diseño, la arquitectura y la ciudad; sumándose el aporte realizado a través de sus respectivas conferencias de Ana Clarisa Agüero, Bibiana Cicutti, Fernando Aliata y Alberto Petrina. El conjunto de ponencias que se publican en este Repositorio de la UNC son el resultado de dos intensas jornadas de exposiciones, cuyos contenidos han posibilitado actualizar viejos dilemas y promover nuevos debates. El evento recibió el apoyo de las autoridades de la FAUD-UNC, en especial de la Secretaría de Investigación y de la Biblioteca de nuestra casa, como así también de la Facultad de Arquitectura de la UCC; va para todos ellos un especial agradecimiento

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Summary Background Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. Methods We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung’s disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. Findings We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung’s disease) from 264 hospitals (89 in high-income countries, 166 in middleincome countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in lowincome countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. Interpretation Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between lowincome, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Studies with butterfly bait traps: an overview

Made available in DSpace on 2019-09-12T16:57:11Z (GMT). No. of bitstreams: 0 Previous issue date: 2014Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)BIOTA-FAPESPIn the last decades, there has been a considerable increase in literature concerning ecological studies employing bait traps to capture butterflies. The growing interest in this kind of studies has given rise to a demanding group of young students and researchers looking for information and standardized protocols. Due to such growing interest in bait trap studies, this review aims to discuss (i) the basic aspects of the main technique of collection and sampling methods, and (ii) alternative solutions of different bait trap surveys in the Neotropics. Common mistakes that could undermine the quality and comparability of obtained data are also discussed.[Lucci Freitas, Andre Victor; Santos, Jessie Pereira; Oliveira Carreira, Junia Yasmin; Batista Rosa, Augusto Henrique; Accacio, Gustavo Mattos] Univ Estadual Campinas, Dept Biol Anim, CP 6109, BR-13083970 Campinas, SP, Brazil[Iserhard, Cristiano Agra] Univ Fed Pelotas, Dept Ecol Zool & Genet, Pelotas, RS, Brazil[Santos, Jessie Pereira; Ribeiro, Danilo Bandini] Univ Fed Mato Grosso do Sul, Ctr Ciencias Biol & Saude, Campo Grande, MS, Brazil[Alves Melo, Douglas Henrique] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil[Batista Rosa, Augusto Henrique] , Inst Basico Biociencias, Dept Biol, Sao Paulo, Brazil[Marini-Filho, Onildo Joao] Inst Chico Mendes Conservacao Biodiversidade ICMB, Ctr Nacl Pesquisa Conservacao Biodiversidade Cerr, Brasilia, DF, Brazil[Uehara-Prado, Marcio] Inst Neotrop Pesquisa & Conservacao, Curitiba, Parana, Brazi

Atlantic butterflies: a data set of fruit-feeding butterfly communities from the Atlantic forests

Made available in DSpace on 2019-09-12T16:53:23Z (GMT). No. of bitstreams: 0 Previous issue date: 2018Butterflies are one of the best-known insect groups, and they have been the subject of numerous studies in ecology and evolution, especially in the tropics. Much attention has been given to the fruit-feeding butterfly guild in biodiversity conservation studies, due to the relative ease with which taxa may be identified and specimens sampled using bait traps. However, there remain many uncertainties about the macroecological and biogeographical patterns of butterflies in tropical ecosystems. In the present study, we gathered information about fruit-feeding butterfly species in local communities from the Atlantic Forests of South America. The ATLANTIC BUTTERFLIES data set, which is part of ATLANTIC SERIES data papers, results from a compilation of 145 unpublished inventories and 64 other references, including articles, theses, and book chapters published from 1949 to 2018. In total, the data set contains 7,062 records (presence) of 279 species of fruit-feeding butterflies identified with taxonomic certainty, from 122 study locations. The Satyrini is the tribe with highest number of species (45%) and records (30%), followed by Brassolini, with 13% of species and 12.5% of records. The 10 most common species correspond to 14.2% of all records. This data set represents a major effort to compile inventories of fruit-feeding butterfly communities, filling a knowledge gap about the diversity and distribution of these butterflies in the Atlantic Forest. We hope that the present data set can provide guidelines for future studies and planning of new inventories of fruit-feeding butterflies in this biome. The information presented here also has potential use in studies across a great variety of spatial scales, from local and landscape levels to macroecological research and biogeographical research. We expect that such studies be very important for the better implementation of conservation initiatives, and for understanding the multiple ecological processes that involve fruit-feeding butterflies as biological indicators. No copyright restrictions apply to the use of this data set. Please cite this Data paper when using the current data in publications or teaching events.[dos Santos, Jessie Pereira; Lucci Freitas, Andre Victor; Brown, Keith Spalding, Jr.; Oliveira Carreira, Junia Yasmin; Gueratto, Patricia Eyng; Batista Rosa, Augusto Henrique; Lourenco, Giselle Martins; Accacio, Gustavo Mattos] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Anim, Campinas, SP, Brazil[Uehara-Prado, Marcio] Inst Neotrop Pesquisa Conservacao, Curitiba, Parana, Brazil[Iserhard, Cristiano Agra; Richter, Aline] Univ Fed Pelotas, Dept Ecol Zool & Genet, Campus Univ Capao Leao, Pelotas, RS, Brazil[Romanowski, Helena Piccoli; Mega, Nicolas Oliveira; Teixeira, Melissa Oliveira; Moser, Alfred] Univ Fed Rio Grande, Dept Zool, Porto Alegre, RS, Brazil[Ribeiro, Danilo Bandini; Araujo, Poliana Felix] Univ Fed Mato Grosso do Sul, Inst Biociencias, Campo Grande, Brazil[Cordeiro Filgueiras, Bruno Karol; Alves Melo, Douglas Henrique] Univ Fed Pernambuco, Dept Zool, Recife, PE, Brazil[Leal, Inara Roberta] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil[Beirao, Marina do Vale] Univ Fed Ouro Preto, Programa Posgrad Ecol Biomas Tropicais, Ouro Preto, MG, Brazil[Ribeiro, Danilo Bandini] Univ Fed Ouro Preto, Dept Biodiversidade, Lab Ecol Evolut Insetos Dossel & Sucessao Nat, Minas Gerais, Brazil[Barbosa Cambui, Elaine Cristina] Univ Fed Bahia, PPG Multiinst Multidisciplinar Difusao Conhecimen, Salvador, BA, Brazil[Vasconcelos, Rodrigo Nogueira] Univ Estadual Feira de Santana, PPG Modelagem Ciecias Terra & Ambiente, Feira De Santana, Brazil[Cardoso, Marcio Zikan] Univ Fed Rio Grande do Norte, Dept Ecol, Natal, RN, Brazil[Paluch, Marlon] Univ Fed Reconcavo Bahia, Cruz Das Almas, BA, Brazil[Greve, Roberto Rezende] Univ Fed Integracao Latino Amer UNILA, Inst Latino Amer Ciencias Vida & Nat, Lab Ecol Metacomunidades, Foz Do Iguacu, Brazil[Voltolini, Julio Cesar] ECOTROP Grp Pesquisa & Ensino Biol Conservacao, Unitau, Dept Biol[Galetti, Mauro] Univ Estadual Sao Paulo UNESP, Inst Biociencias, Dept Ecol, Rio Claro, SP, Brazil[Regolin, Andre Luis; Sobral-Souza, Thadeu; Ribeiro, Milton Cezar] Univ Estadual Sao Paulo UNESP, Inst Biociencias, Dept Ecol, Lab Ecol Espacial Conservacao LEEC, Rio Claro, SP, Brazi